Be part of a thought-provoking discussion about the paradigm shift in cancer prognosis, from generalised predictions to individualised risk assessments based on genetic makeup. Experts will explore how this approach has transformed cancer research, and how this may impact on patient outcomes based on their unique characteristics and needs.
The speakers will address some key cancer conundrums faced by both the medical and general communities.
Facilitated by Professor Corinna Van Den Heuvel Head of School, School of Biomedicine, University of Adelaide
Speakers:
Professor Charles Mullighan
Deputy Director, Comprehensive Cancer Centre St Jude Children’s Research Hospital, Memphis
Professor Jane Visvader
Joint Division Head, ACRF Cancer Biology and Stem Cells, Walter and Eliza Hall Institute of Medical Research, Melbourne
Professor Christopher Sweeney
Professor Christopher Sweeney is the inaugural Director of the South Australian immunoGENomics Cancer Institute (SAIGENCI) at the University of Adelaide.
More info:
www.adelaide.edu.au/make-hist...
25 сен 2023
